NASDAQ
Acumen Pharmaceuticals, Inc. (ABOS) has a interest coverage ratio of -29.32x as of Wednesday, July 15, 2026. This represents a 12.00% increase compared to its 12-month average of -33.31x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.